Skip to content
naulon

No retraction, correction or concern found when last checked on Oct 24, 2026.

Selection of reference genes for quantitative real-time PCR in a rat asphyxial cardiac arrest model

Kristina Langnaese, Robin John, Hannes Schweizer and 2 more

BMC Molecular Biology · 2008

doi:10.1186/1471-2199-9-53

Abstract

Background. Cardiac arrest, and the associated arrest of blood circulation, immediately leads to permanent brain damage because of the exhaustion of oxygen, glucose and energy resources in the brain. Most hippocampal CA1 neurons die during the first week post the insult. Molecular data concerning the recovery after resuscitation are sparse and limited to the early time period. Expression analysis of marker genes via quantitative real-time RT-PCR enables to follow up the remodeling process. However, proper validation of the applied normalization strategy is a crucial prerequisite for reliable conclusions. Therefore, the present study aimed to determine the expression stability of ten commonly used reference genes (Actb, actin, beta; B2m, beta-2 microglobulin;CypA, cyclophilin A; Gapdh, glyceraldehyde-3-phosphate dehydrogenase; Hprt, hypoxanthine guanine phosphoribosyl transferase; Pgk1, phosphoglycerate kinase 1; Rpl13a, ribosomal protein L13A; Sdha, succinat dehydrogenase complex, subunit a, flavoprotein (Fp); Tbp, TATA box binding protein; Ywhaz, tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, zeta polypeptide) in the rat hippocampus four, seven and twenty-one days after cardiac arrest. Moreover, experimental groups treated with the anti-inflammatory and anti-apoptotic drug minocycline have been included in the study as well.

Results. The microglial marker Mac-1, used as a target gene to validate the experimental model, was found to be upregulated about 10- to 20-fold after cardiac arrest. Expression stability of candidate reference genes was analyzed using geNorm and NormFinder software tools. Several of these genes behave rather stable. CypA and Pgk1 were identified by geNorm as the two most stable genes 4 and 21 days after asphyxial cardiac arrest, CypA and Gapdh at 7 days post treatment. B2m turned out to be the most variable candidate reference gene, being about 2-fold upregulated in the cardiac arrest treatment groups.

Conclusion. We have validated endogenous control genes for qRT-PCR analysis of gene expression in rat hippocampus after resuscitation from cardiac arrest. For normalization purposes in gene profiling studies a combination of CypA and Pgk1 should be considered 4 and 21 days post injury, whereas CypA and Gapdh is the best combination at 7 days. CypA is most favorable if restriction to a single reference gene for all time points is required.

References 56

  1. 1.

    Cole SL, Corday E. Four-minute limit for cardiac resuscitation. J Am Med Assoc. 1956;161:1454-1458.

    Not in our library10.1001/jama.1956.02970150022005

  2. 2.

    Safar P. Cerebral resuscitation after cardiac arrest: a review. Circulation. 1986;74:IV138-153.

    Not in our library

  3. 3.

    Ebmeyer U, Keilhoff G, Wolf G, Rose W. Strain specific differences in a cardio-pulmonary resuscitation rat model. Resuscitation. 2002;53:189-200.

    Not in our library10.1016/s0300-9572(02)00003-5

  4. 4.

    Hicks SD, DeFranco DB, Callaway CW. Hypothermia during reperfusion after asphyxial cardiac arrest improves functional recovery and selectively alters stress-induced protein expression. J Cereb Blood Flow Metab. 2000;20:520-530.

    Not in our library10.1097/00004647-200003000-00011

  5. 5.

    Hickey RW, Zhu RL, Alexander HL, Jin KL, Stetler RA, Chen J, Kochanek PM, Graham SH. 10 kD mitochondrial matrix heat shock protein mRNA is induced following global brain ischemia in the rat. Brain Res Mol Brain Res. 2000;79:169-173.

    Not in our library10.1016/s0169-328x(00)00113-3

  6. 6.

    Katz LM, Lotocki G, Wang Y, Kraydieh S, Dietrich WD, Keane RW. Regulation of caspases and XIAP in the brain after asphyxial cardiac arrest in rats. Neuroreport. 2001;12:3751-3754.

    Not in our library10.1097/00001756-200112040-00029

  7. 7.

    Li ZP, Chen SQ, Wang SS, Huang WJ, Cheng JY, Wang W, Wang WT, Tan YX. [Expression of mRNA of matrix metalloproteinase and tissue inhibitor of matrix metalloproteinase after cardiopulmonary resuscitation for asphyxial cardiac arrest in rat]. Zhongguo Wei Zhong Bing Ji Jiu Yi Xue. 2005;17:548-551.

    Not in our library

  8. 8.

    Vosler PS, Logue ES, Repine MJ, Callaway CW. Delayed hypothermia preferentially increases expression of brain-derived neurotrophic factor exon III in rat hippocampus after asphyxial cardiac arrest. Brain Res Mol Brain Res. 2005;135:21-29.

    Not in our library10.1016/j.molbrainres.2004.11.006

  9. 9.

    D'Cruz BJ, Fertig KC, Filiano AJ, Hicks SD, DeFranco DB, Callaway CW. Hypothermic reperfusion after cardiac arrest augments brain-derived neurotrophic factor activation. J Cereb Blood Flow Metab. 2002;22:843-851.

    Not in our library10.1097/00004647-200207000-00009

  10. 10.

    Huggett J, Dheda K, Bustin S, Zumla A. Real-time RT-PCR normalisation; strategies and considerations. Genes Immun. 2005;6:279-284.

    Not in our library10.1038/sj.gene.6364190

  11. 11.

    Andersen CL, Jensen JL, Orntoft TF. Normalization of real-time quantitative reverse transcription-PCR data: a model-based variance estimation approach to identify genes suited for normalization, applied to bladder and colon cancer data sets. Cancer Res. 2004;64:5245-5250.

    Not in our library10.1158/0008-5472.can-04-0496

  12. 12.

    Bustin SA. Quantification of mRNA using real-time reverse transcription PCR (RT-PCR): trends and problems. J Mol Endocrinol. 2002;29:23-39.

    Not in our library10.1677/jme.0.0290023

  13. 13.

    Bonefeld BE, Elfving B, Wegener G. Reference genes for normalization: A study of rat brain tissue. Synapse. 2008;62:302-309.

    Not in our library10.1002/syn.20496

  14. 14.

    Ohl F, Jung M, Radonic A, Sachs M, Loening SA, Jung K. Identification and validation of suitable endogenous reference genes for gene expression studies of human bladder cancer. J Urol. 2006;175:1915-1920.

    Not in our library10.1016/s0022-5347(05)00919-5

  15. 15.

    Pombo-Suarez M, Calaza M, Gomez-Reino JJ, Gonzalez A. Reference genes for normalization of gene expression studies in human osteoarthritic articular cartilage. BMC Mol Biol. 2008;9:17.

    Not in our library10.1186/1471-2199-9-17

  16. 16.
  17. 17.

    Dheda K, Huggett JF, Chang JS, Kim LU, Bustin SA, Johnson MA, Rook GA, Zumla A. The implications of using an inappropriate reference gene for real-time reverse transcription PCR data normalization. Anal Biochem. 2005;344:141-143.

    Not in our library10.1016/j.ab.2005.05.022

  18. 18.

    Dheda K, Huggett JF, Bustin SA, Johnson MA, Rook G, Zumla A. Validation of housekeeping genes for normalizing RNA expression in real-time PCR. Biotechniques. 2004;37:112-114.

    Not in our library10.2144/04371rr03

  19. 19.

    Vandesompele J, De Preter K, Pattyn F, Poppe B, Van Roy N, De Paepe A, Speleman F. Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol. 2002;3:RESEARCH0034.

    Not in our library10.1186/gb-2002-3-7-research0034

  20. 20.

    Smilack JD. The tetracyclines. Mayo Clin Proc. 1999;74:727-729.

    Not in our library10.4065/74.7.727

  21. 21.

    Blum D, Chtarto A, Tenenbaum L, Brotchi J, Levivier M. Clinical potential of minocycline for neurodegenerative disorders. Neurobiol Dis. 2004;17:359-366.

    Not in our library10.1016/j.nbd.2004.07.012

  22. 22.

    Yong VW, Wells J, Giuliani F, Casha S, Power C, Metz LM. The promise of minocycline in neurology. Lancet Neurol. 2004;3:744-751.

    Not in our library10.1016/s1474-4422(04)00937-8

  23. 23.

    Stirling DP, Koochesfahani KM, Steeves JD, Tetzlaff W. Minocycline as a neuroprotective agent. Neuroscientist. 2005;11:308-322.

    Not in our library10.1177/1073858405275175

  24. 24.

    Elewa HF, Hilali H, Hess DC, Machado LS, Fagan SC. Minocycline for short-term neuroprotection. Pharmacotherapy. 2006;26:515-521.

    Not in our library10.1592/phco.26.4.515

  25. 25.

    Yrjanheikki J, Tikka T, Keinanen R, Goldsteins G, Chan PH, Koistinaho J. A tetracycline derivative, minocycline, reduces inflammation and protects against focal cerebral ischemia with a wide therapeutic window. Proc Natl Acad Sci USA. 1999;96:13496-13500.

    Not in our library10.1073/pnas.96.23.13496

  26. 26.

    Xu L, Fagan SC, Waller JL, Edwards D, Borlongan CV, Zheng J, Hill WD, Feuerstein G, Hess DC. Low dose intravenous minocycline is neuroprotective after middle cerebral artery occlusion-reperfusion in rats. BMC Neurol. 2004;4:7.

    Not in our library10.1186/1471-2377-4-7

  27. 27.

    Wang CX, Yang T, Shuaib A. Effects of minocycline alone and in combination with mild hypothermia in embolic stroke. Brain Res. 2003;963:327-329.

    Not in our library10.1016/s0006-8993(02)04045-3

  28. 28.

    Weng YC, Kriz J. Differential neuroprotective effects of a minocycline-based drug cocktail in transient and permanent focal cerebral ischemia. Exp Neurol. 2007;204:433-442.

    Not in our library10.1016/j.expneurol.2006.12.003

  29. 29.

    Koistinaho M, Malm TM, Kettunen MI, Goldsteins G, Starckx S, Kauppinen RA, Opdenakker G, Koistinaho J. Minocycline protects against permanent cerebral ischemia in wild type but not in matrix metalloprotease-9-deficient mice. J Cereb Blood Flow Metab. 2005;25:460-467.

    Not in our library10.1038/sj.jcbfm.9600040

  30. 30.

    Zhang Z, Harrison PM, Liu Y, Gerstein M. Millions of years of evolution preserved: a comprehensive catalog of the processed pseudogenes in the human genome. Genome Res. 2003;13:2541-2558.

    Not in our library10.1101/gr.1429003

  31. 31.

    Bustin SA. A-Z of quantitative PCR. 2004.

    Not in our library

  32. 32.

    Stoll G, Jander S. The role of microglia and macrophages in the pathophysiology of the CNS. Prog Neurobiol. 1999;58:233-247.

    Not in our library10.1016/s0301-0082(98)00083-5

  33. 33.

    Ropenga A, Chapel A, Vandamme M, Griffiths NM. Use of reference gene expression in rat distal colon after radiation exposure: a caveat. Radiat Res. 2004;161:597-602.

    Not in our library10.1667/rr3173

  34. 34.

    Mutimer H, Deacon N, Crowe S, Sonza S. Pitfalls of processed pseudogenes in RT-PCR. Biotechniques. 1998;24:585-588.

    Not in our library10.2144/98244bm16

  35. 35.

    Willems E, Mateizel I, Kemp C, Cauffman G, Sermon K, Leyns L. Selection of reference genes in mouse embryos and in differentiating human and mouse ES cells. Int J Dev Biol. 2006;50:627-635.

    Not in our library10.1387/ijdb.052130ew

  36. 36.

    Lipton P. Ischemic cell death in brain neurons. Physiol Rev. 1999;79:1431-1568.

    Not in our library10.1152/physrev.1999.79.4.1431

  37. 37.

    Wang Q, Tang XN, Yenari MA. The inflammatory response in stroke. J Neuroimmunol. 2007;184:53-68.

    Not in our library10.1016/j.jneuroim.2006.11.014

  38. 38.

    Bemeur C, Ste-Marie L, Desjardins P, Hazell AS, Vachon L, Butterworth R, Montgomery J. Decreased beta-actin mRNA expression in hyperglycemic focal cerebral ischemia in the rat. Neurosci Lett. 2004;357:211-214.

    Not in our library10.1016/j.neulet.2003.12.081

  39. 39.

    Harrison DC, Medhurst AD, Bond BC, Campbell CA, Davis RP, Philpott KL. The use of quantitative RT-PCR to measure mRNA expression in a rat model of focal ischemia – caspase-3 as a case study. Brain Res Mol Brain Res. 2000;75:143-149.

    Not in our library10.1016/s0169-328x(99)00305-8

  40. 40.

    Lennmyr F, Terent A, Syvanen AC, Barbany G. Vascular endothelial growth factor gene expression in middle cerebral artery occlusion in the rat. Acta Anaesthesiol Scand. 2005;49:488-493.

    Not in our library10.1111/j.1399-6576.2005.00646.x

  41. 41.

    Tian YF, Zhang PB, Xiao XL, Zhang JS, Zhao JJ, Kang QY, Chen XL, Qiu F, Liu Y. The quantification of ADAMTS expression in an animal model of cerebral ischemia using real-time PCR. Acta Anaesthesiol Scand. 2007;51:158-164.

    Not in our library10.1111/j.1399-6576.2006.01161.x

  42. 42.

    Bond BC, Virley DJ, Cairns NJ, Hunter AJ, Moore GB, Moss SJ, Mudge AW, Walsh FS, Jazin E, Preece P. The quantification of gene expression in an animal model of brain ischaemia using TaqMan real-time RT-PCR. Brain Res Mol Brain Res. 2002;106:101-116.

    Not in our library10.1016/s0169-328x(02)00417-5

  43. 43.

    Nishida Y, Sugahara-Kobayashi M, Takahashi Y, Nagata T, Ishikawa K, Asai S. Screening for control genes in mouse hippocampus after transient forebrain ischemia using high-density oligonucleotide array. J Pharmacol Sci. 2006;101:52-57.

    Not in our library10.1254/jphs.fp0050881

  44. 44.

    Kobayashi MS, Takahashi Y, Nagata T, Nishida Y, Murata A, Ishikawa K, Asai S. Screening for control genes in rat global cerebral ischemia using high-density oligonucleotide array. J Neurosci Res. 2004;76:512-518.

    Not in our library10.1002/jnr.20094

  45. 45.

    Meldgaard M, Fenger C, Lambertsen KL, Pedersen MD, Ladeby R, Finsen B. Validation of two reference genes for mRNA level studies of murine disease models in neurobiology. J Neurosci Methods. 2006;156:101-110.

    Not in our library10.1016/j.jneumeth.2006.02.008

  46. 46.

    Peinnequin A, Mouret C, Birot O, Alonso A, Mathieu J, Clarencon D, Agay D, Chancerelle Y, Multon E. Rat pro-inflammatory cytokine and cytokine related mRNA quantification by real-time polymerase chain reaction using SYBR green. BMC Immunol. 2004;5:3.

    Not in our library10.1186/1471-2172-5-3

  47. 47.

    Raghavendra V, Tanga FY, DeLeo JA. Complete Freunds adjuvant-induced peripheral inflammation evokes glial activation and proinflammatory cytokine expression in the CNS. Eur J Neurosci. 2004;20:467-473.

    Not in our library10.1111/j.1460-9568.2004.03514.x

  48. 48.

    Rozen S, Skaletsky H. Primer3 on the WWW for general users and for biologist programmers. Methods Mol Biol. 2000;132:365-386.

    Not in our library10.1385/1-59259-192-2:365

  49. 49.

    GenBank.

    Not in our library

  50. 50.

    geNorm.

    Not in our library

  51. 51.

    NormFinder.

    Not in our library

  52. 52.

    Relative expression software tool (REST).

    Not in our library

  53. 53.

    Pfaffl MW, Horgan GW, Dempfle L. Relative expression software tool (REST) for group-wise comparison and statistical analysis of relative expression results in real-time PCR. Nucleic Acids Res. 2002;30:e36.

    Not in our library10.1093/nar/30.9.e36

  54. 54.

    Entrez Gene.

    Not in our library

  55. 55.

    geNorm software manual.

    Not in our library

  56. 56.

    NormFinder – How to.

    Not in our library

Cited by papers we hold 5

Reads

Read by people on this page

None yet.

Checked or read by AI through naulon

None yet.

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.

Are you an author?

Is this your paper?

Claim it to add your note and be paid when agents cite it. Free.